These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

721 related items for PubMed ID: 31463807

  • 1. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
    Song J, Li Y, Bowlus CL, Yang G, Leung PSC, Gershwin ME.
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
    [Abstract] [Full Text] [Related]

  • 2. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB, Jacobson IM.
    Rev Gastroenterol Disord; 2009 Feb; 9(2):E41-7. PubMed ID: 19668124
    [Abstract] [Full Text] [Related]

  • 3. Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
    Grimsrud MM, Folseraas T.
    Liver Int; 2019 Dec; 39(12):2230-2237. PubMed ID: 31216595
    [Abstract] [Full Text] [Related]

  • 4. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices.
    Fung BM, Tabibian JH.
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):487-496. PubMed ID: 33682586
    [Abstract] [Full Text] [Related]

  • 5. Cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Fung BM, Tabibian JH.
    Curr Opin Gastroenterol; 2020 Mar; 36(2):77-84. PubMed ID: 31850928
    [Abstract] [Full Text] [Related]

  • 6. Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis.
    Saca D, Flamm SL.
    Clin Liver Dis; 2024 Feb; 28(1):183-192. PubMed ID: 37945159
    [Abstract] [Full Text] [Related]

  • 7. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
    Ehlken H, Schramm C.
    Dig Dis; 2013 Feb; 31(1):118-25. PubMed ID: 23797133
    [Abstract] [Full Text] [Related]

  • 8. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
    Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H.
    Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
    [Abstract] [Full Text] [Related]

  • 9. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN, Gores GJ.
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [Abstract] [Full Text] [Related]

  • 10. Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillance.
    Ehlken H, Zenouzi R, Schramm C.
    Curr Opin Gastroenterol; 2017 Mar; 33(2):78-84. PubMed ID: 28146445
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology of cholangiocarcinoma.
    Bergquist A, von Seth E.
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
    [Abstract] [Full Text] [Related]

  • 12. Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
    Bonato G, Cristoferi L, Strazzabosco M, Fabris L.
    Dig Dis; 2015 Apr; 33 Suppl 2(Suppl 2):140-8. PubMed ID: 26641079
    [Abstract] [Full Text] [Related]

  • 13. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P, Karvonen AL, Laukkarinen J, Aitola P, Huhtala H, Collin P.
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [Abstract] [Full Text] [Related]

  • 14. Metal, magnet or transplant: options in primary sclerosing cholangitis with stricture.
    Ahmad J.
    Hepatol Int; 2018 Nov; 12(6):510-519. PubMed ID: 30430358
    [Abstract] [Full Text] [Related]

  • 15. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Fevery J, Verslype C, Lai G, Aerts R, Van Steenbergen W.
    Dig Dis Sci; 2007 Nov; 52(11):3123-35. PubMed ID: 17431781
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
    Taghavi SA, Eshraghian A, Niknam R, Sivandzadeh GR, Bagheri Lankarani K.
    Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):575-584. PubMed ID: 29781738
    [Abstract] [Full Text] [Related]

  • 17. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
    Lapitz A, Azkargorta M, Milkiewicz P, Olaizola P, Zhuravleva E, Grimsrud MM, Schramm C, Arbelaiz A, O'Rourke CJ, La Casta A, Milkiewicz M, Pastor T, Vesterhus M, Jimenez-Agüero R, Dill MT, Lamarca A, Valle JW, Macias RIR, Izquierdo-Sanchez L, Pérez Castaño Y, Caballero-Camino FJ, Riaño I, Krawczyk M, Ibarra C, Bustamante J, Nova-Camacho LM, Falcon-Perez JM, Elortza F, Perugorria MJ, Andersen JB, Bujanda L, Karlsen TH, Folseraas T, Rodrigues PM, Banales JM.
    J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
    [Abstract] [Full Text] [Related]

  • 18. Outruling cholangiocarcinoma in patients with primary sclerosing cholangitis wait-listed for liver transplantation: A report on the Irish national experience.
    Duggan WP, Brosnan C, Christodoulides N, Nolan N, Kambakamba P, Gallagher TK.
    Surgeon; 2023 Apr; 21(2):e83-e88. PubMed ID: 35680491
    [Abstract] [Full Text] [Related]

  • 19. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
    Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD.
    Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
    [Abstract] [Full Text] [Related]

  • 20. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, Stribling RJ, Goldstein LI, Busuttil RW.
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.